Mehta Vimal has filed 87 insider transactions across 1 company since November 2022.
Most recent transaction: a option exercise of 219 shares of BioXcel Therapeutics, Inc. ($BTAI) on March 15, 2026.
Activity breakdown: 0 open-market purchases and 25 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 501,727.0000 | 14,196,000 | 0.04% | 0.00% |
| March 14, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 164 | $0.00 | 501,508.0000 | 14,196,000 | 0.03% | 0.00% |
| March 14, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 164 | $0.00 | 488.0000 | 14,196,000 | 25.15% | 0.00% |
| March 15, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 1,532.0000 | 14,196,000 | 12.51% | 0.00% |
| Jan. 1, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Restricted Stock Units | 199032 | $0.00 | 200,783.0000 | 14,196,000 | 9999.99% | 1.40% |
| Dec. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 501,344.0000 | 14,196,000 | 0.04% | 0.00% |
| Dec. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 1,751.0000 | 14,196,000 | 11.12% | 0.00% |
| Dec. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 164 | $0.00 | 501,125.0000 | 14,196,000 | 0.03% | 0.00% |
| Dec. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 164 | $0.00 | 652.0000 | 14,196,000 | 20.10% | 0.00% |
| Sept. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 163 | $0.00 | 816.0000 | 7,843,000 | 16.65% | 0.00% |
| Sept. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 163 | $0.00 | 500,742.0000 | 7,843,000 | 0.03% | 0.00% |
| Sept. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 500,961.0000 | 7,843,000 | 0.04% | 0.00% |
| Sept. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 1,970.0000 | 7,843,000 | 10.00% | 0.00% |
| Aug. 1, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Restricted Stock Units | 18000 | $0.00 | 18,000.0000 | 7,843,000 | 9999.99% | 0.23% |
| July 22, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Common Stock | 15625 | $0.00 | 500,579.0000 | 7,843,000 | 3.22% | 0.20% |
| June 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 484,954.0000 | 4,834,000 | 0.05% | 0.00% |
| June 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 163 | $0.00 | 484,735.0000 | 4,834,000 | 0.03% | 0.00% |
| June 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 2,189.0000 | 4,834,000 | 9.09% | 0.00% |
| June 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 163 | $0.00 | 979.0000 | 4,834,000 | 14.27% | 0.00% |
| July 22, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 2,516,000 | 9999.99% | 0.25% |
| March 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 162 | $0.00 | 484,355.0000 | 2,535,000 | 0.03% | 0.01% |
| March 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 217 | $0.00 | 484,572.0000 | 2,535,000 | 0.04% | 0.01% |
| March 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 162 | $0.00 | 1,142.0000 | 2,535,000 | 12.42% | 0.01% |
| March 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 217 | $0.00 | 2,408.0000 | 2,535,000 | 8.27% | 0.01% |
| Jan. 7, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Stock Option (right to buy) | 660000 | $0.00 | 660,000.0000 | 2,535,000 | 9999.99% | 26.04% |
| Dec. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 3500 | $0.00 | 7,749,404.0000 | 2,649,000 | 0.05% | 0.13% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 983 | $0.36 | 7,748,421.0000 | 2,649,000 | 0.01% | 0.04% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 2134 | $0.36 | 7,747,106.0000 | 2,649,000 | 0.03% | 0.08% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2610 | $0.00 | 13,049.0000 | 2,649,000 | 16.67% | 0.10% |
| Dec. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 3500 | $0.00 | 31,500.0000 | 2,649,000 | 10.00% | 0.13% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2610 | $0.00 | 7,745,904.0000 | 2,649,000 | 0.03% | 0.10% |
| Sept. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 1150 | $0.69 | 7,739,167.0000 | 2,516,000 | 0.01% | 0.05% |
| Sept. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 832 | $0.69 | 7,740,317.0000 | 2,516,000 | 0.01% | 0.03% |
| Sept. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 3500 | $0.00 | 7,741,149.0000 | 2,516,000 | 0.05% | 0.14% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 7,737,649.0000 | 2,516,000 | 0.03% | 0.10% |
| Sept. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 3500 | $0.00 | 35,000.0000 | 2,516,000 | 9.09% | 0.14% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 15,657.0000 | 2,516,000 | 14.28% | 0.10% |
| June 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 3500 | $0.00 | 38,500.0000 | 1,929,000 | 8.33% | 0.18% |
| June 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 2134 | $1.28 | 7,735,040.0000 | 1,929,000 | 0.03% | 0.11% |
| June 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 3500 | $0.00 | 7,737,174.0000 | 1,929,000 | 0.05% | 0.18% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 7,733,674.0000 | 1,929,000 | 0.03% | 0.14% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 18,266.0000 | 1,929,000 | 12.50% | 0.14% |
| June 5, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 126014 | $1.58 | 7,731,065.0000 | 1,929,000 | 1.60% | 6.53% |
| June 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 609221 | $0.00 | 7,983,093.0000 | 1,929,000 | 7.09% | 31.58% |
| June 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 283123 | $0.00 | 8,014,187.0000 | 1,929,000 | 3.41% | 14.68% |
| June 5, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 283122 | $0.00 | 7,731,065.0000 | 1,929,000 | 3.53% | 14.68% |
| June 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 126014 | $1.63 | 7,857,079.0000 | 1,929,000 | 1.58% | 6.53% |
| June 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Call Options (obligation to sell) | 120 | $0.00 | 120.0000 | 1,929,000 | 50.00% | 0.01% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 14000 | $0.00 | 42,000.0000 | 1,821,000 | 25.00% | 0.77% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2610 | $0.00 | 20,875.0000 | 1,821,000 | 11.11% | 0.14% |
| April 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 4439 | $2.62 | 8,592,314.0000 | 1,929,000 | 0.05% | 0.23% |
| April 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 829 | $2.62 | 8,596,753.0000 | 1,929,000 | 0.01% | 0.04% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 14000 | $0.00 | 8,597,582.0000 | 1,821,000 | 0.16% | 0.77% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2610 | $0.00 | 8,583,582.0000 | 1,821,000 | 0.03% | 0.14% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 23,485.0000 | 29,268,000 | 10.00% | 0.01% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 8,580,972.0000 | 29,268,000 | 0.03% | 0.01% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2610 | $0.00 | 26,094.0000 | 29,187,000 | 9.09% | 0.01% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2610 | $0.00 | 31,613.0000 | 29,187,000 | 9.00% | 0.01% |
| June 16, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 24987 | $20.01 | 46,916.0000 | 28,616,000 | 34.75% | 0.09% |
| June 16, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 4266 | $20.90 | 42,650.0000 | 28,616,000 | 9.09% | 0.01% |
| June 16, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 747 | $21.89 | 41,903.0000 | 28,616,000 | 1.75% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 28,704.0000 | 28,616,000 | 8.33% | 0.01% |
| June 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 324,000.0000 | 28,616,000 | 8.47% | 0.10% |
| June 16, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 294,000.0000 | 28,616,000 | 9.26% | 0.10% |
| June 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 71,903.0000 | 28,616,000 | 71.59% | 0.10% |
| June 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 21988 | $21.41 | 49,915.0000 | 28,616,000 | 30.58% | 0.08% |
| June 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 8012 | $21.90 | 41,903.0000 | 28,616,000 | 16.05% | 0.03% |
| June 16, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 71,903.0000 | 28,616,000 | 71.59% | 0.10% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 41,903.0000 | 28,616,000 | 6.64% | 0.01% |
| May 22, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 6500 | $25.79 | 39,294.0000 | 28,616,000 | 14.19% | 0.02% |
| May 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 15000 | $0.00 | 32,894.0000 | 28,616,000 | 83.83% | 0.05% |
| May 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 15000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.05% |
| March 21, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 8,594,644.0000 | 28,015,000 | 0.35% | 0.11% |
| March 21, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 29100 | $19.70 | 8,565,544.0000 | 28,015,000 | 0.34% | 0.10% |
| March 21, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 900 | $20.15 | 8,564,644.0000 | 28,015,000 | 0.01% | 0.00% |
| March 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 384,000.0000 | 28,015,000 | 7.25% | 0.11% |
| March 21, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 354,000.0000 | 28,015,000 | 7.81% | 0.11% |
| March 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 5333 | $18.86 | 8,569,144.0000 | 28,015,000 | 0.06% | 0.02% |
| March 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 3896 | $18.22 | 8,565,248.0000 | 28,015,000 | 0.05% | 0.01% |
| March 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 604 | $18.88 | 8,564,644.0000 | 28,015,000 | 0.01% | 0.00% |
| March 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 8,599,144.0000 | 28,015,000 | 0.35% | 0.11% |
| March 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | S | Common Stock | 24667 | $18.20 | 8,574,477.0000 | 28,015,000 | 0.29% | 0.09% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Common Stock | 10437 | $0.00 | 8,569,144.0000 | 28,015,000 | 0.12% | 0.04% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Restricted Stock Units | 56000 | $0.00 | 56,000.0000 | 28,015,000 | 9999.99% | 0.20% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | M | Restricted Stock Units | 10437 | $0.00 | 31,313.0000 | 28,015,000 | 25.00% | 0.04% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | A | Stock Option (Right to Buy) | 168000 | $0.00 | 168,000.0000 | 28,015,000 | 9999.99% | 0.60% |
| Nov. 15, 2022 | BioXcel Therapeutics, Inc. | $BTAI | Mehta Vimal | CEO and President | G | Common Stock | 145549 | $0.00 | 8,558,707.0000 | 28,022,000 | 1.67% | 0.52% |